A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Abbott Laboratories stock. As of the latest transaction made, Two Sigma Advisers, LP holds 4,657,200 shares of ABT stock, worth $533 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
4,657,200
Previous 2,019,000 130.67%
Holding current value
$533 Million
Previous $229 Million 110.88%
% of portfolio
1.1%
Previous 0.54%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $266 Million - $297 Million
2,638,200 Added 130.67%
4,657,200 $484 Million
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $218 Million - $241 Million
1,990,200 Added 6910.42%
2,019,000 $229 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $35.2 Million - $43.1 Million
-390,400 Reduced 93.13%
28,800 $3.17 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $25 Million - $30.1 Million
262,200 Added 167.01%
419,200 $40.6 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $41 Million - $45.7 Million
-407,300 Reduced 72.18%
157,000 $17.1 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $9.96 Million - $11.7 Million
102,800 Added 22.28%
564,300 $57.1 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $41.3 Million - $48.5 Million
-434,900 Reduced 48.52%
461,500 $50.7 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $43.9 Million - $50.8 Million
453,600 Added 102.44%
896,400 $86.7 Million
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $14.4 Million - $17.4 Million
140,900 Added 46.67%
442,800 $48.1 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $1.2 Million - $1.46 Million
-10,500 Reduced 3.36%
301,900 $35.7 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $201 Million - $246 Million
-1,738,861 Reduced 84.77%
312,400 $44 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $139 Million - $154 Million
-1,191,900 Reduced 36.75%
2,051,261 $242 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $299 Million - $352 Million
2,829,600 Added 684.2%
3,243,161 $376 Million
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $15.7 Million - $18.5 Million
144,500 Added 53.71%
413,561 $49.6 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $7.4 Million - $8.07 Million
70,500 Added 35.51%
269,061 $29.5 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $136 Million - $165 Million
-1,480,000 Reduced 88.17%
198,561 $21.6 Million
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $86.6 Million - $111 Million
1,130,761 Added 206.42%
1,678,561 $153 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $23.6 Million - $34.5 Million
375,039 Added 217.09%
547,800 $43.2 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $5.16 Million - $5.75 Million
65,761 Added 61.46%
172,761 $15 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $7.32 Million - $7.93 Million
89,400 Added 507.95%
107,000 $8.95 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $1.28 Million - $1.5 Million
17,600 New
17,600 $1.48 Million
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $4.69 Million - $5.65 Million
-77,060 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $4.44 Million - $4.9 Million
77,060 New
77,060 $4.7 Million
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $7.76 Million - $8.78 Million
-137,936 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $7.4 Million - $7.93 Million
137,936
137,936 $7.87 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.